Compare ARK Genomic Revolution ETF (ARKG) vs ProShares Ultra Bitcoin ETF (BITU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs ProShares Ultra Bitcoin ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while ProShares Ultra Bitcoin ETF trades at $9.23. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, ProShares Ultra Bitcoin ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | BITU | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $43.57 | $64.41 |
52-Week Low | $23.09 | $8.12 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BITU trades at $9.50, up 2.15% with neutral technical indicators showing mixed signals between moving averages and oscillators. The stock faces resistance at $10 with support at $9. Recent dividend payments of $0.01 per share demonstrate capital return commitment, though key financial ratios remain undisclosed in current filings.
The leveraged ETF structure presents both opportunity and risk, with technical analysis indicating near-term consolidation. Investors face volatility decay concerns highlighted in recent analyst reports, while the dividend yield provides income support amid uncertain market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About ProShares Ultra Bitcoin ETF
BITU is a leveraged ETF that seeks to provide two times (2x) the daily performance of Bitcoin. It is designed for sophisticated investors looking for magnified exposure to Bitcoin’s daily price movements.
Read more on BITU →
